drugset / Trial / NCT05895929

The Role of IL5 in Epithelial Cell Integrity

NCT05895929

Phase 0 Completed 17 enrolled Johns Hopkins University GlaxoSmithKline · collab
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The goal of this laboratory study is the examine the effect of mepolizumab drug on the health and function of the cells lining the human nasal airways in vitro cell culture derived from patients with chronic rhinosinusitis with nasal polyposis. The main questions the study aims to study are: 1. To see what mepolizumab does to suppress inflammation of the human cells. 2. To see what mepolizumab does to maintain barrier integrity of epithelial cells

Timeline

Start
2023-09-05
Primary completion
2025-12-31
Completion
2026-02-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Mepolizumab Monoclonal antibody